Angioedema of the upper aerodigestive tract: Risk factors associated with airway intervention and management algorithm

International Forum of Allergy and Rhinology

Volumn 4, Issue 3, 2014, Pages 239-245

  Brook, Christopher D ^a   Devaiah, Anand K ^a   Davis, Elizabeth M ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

Airway; Angioedema; Disposition; Endoscopy; Intubation

Indexed keywords

ADULT; AERODIGESTIVE TRACT; AIRWAY OBSTRUCTION; ALGORITHM; ANALYSIS OF VARIANCE; ANGIONEUROTIC EDEMA; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIGESTIVE SYSTEM; DISEASE COURSE; EARLY INTERVENTION; EMERGENCY WARD; ENDOBRONCHIAL INTUBATION; FACE EDEMA; FEMALE; FIBER OPTICS; HUMAN; LARYNGOSCOPY; LARYNX EDEMA; LIP; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OTOLARYNGOLOGIST; OTORHINOLARYNGOLOGY; PHARYNX; PRIORITY JOURNAL; RESPIRATION CONTROL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

AIRWAY; ANGIOEDEMA; DISPOSITION; ENDOSCOPY; INTUBATION;

AGE FACTORS; AIRWAY OBSTRUCTION; ALGORITHMS; ANGIOEDEMA; COMORBIDITY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INTUBATION, INTRATRACHEAL; LARYNGOSCOPY; MALE; MIDDLE AGED; RESPIRATORY SYSTEM; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84895486234     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21260     Document Type: Article

References (9)

1. Caballero T, Baeza ML, Cabañas R, et al.; Spanish Study Group on Bradykinin-Induced Angioedema; Grupo Español de Estudio del Angioedema mediado por Bradicinina. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol. 2011;21:333-347; quiz follow 347. Review. [Erratum in J Investig Allergol Clin Immunol. 2012;22:unnumbered page following 153.]
2. Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE. Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension. 2008;51:1624-1630.
3. Mahoney EJ, Devaiah AK. Angioedema and angiotensin-converting enzyme inhibitors: are demographics a risk? Otolaryngol Head Neck Surg. 2008;139:105-108.
4. McCormick M, Folbe AJ, Lin HS, Hooten J, Yoo GH, Krouse JH. Site involvement as a predictor of airway intervention in angioedema. Laryngoscope. 2011;121:262-266.
5. Grant NN, Deeb ZE, Chia SH. Clinical experience with angiotensin-converting enzyme inhibitor-induced angioedema. Otolaryngol Head Neck Surg. 2007;137:931-935.
6. Ishoo E, Shah UK, Grillone GA, Stram JR, Fuleihan NS. Predicting airway risk in angioedema: staging system based on presentation. Otolaryngol Head Neck Surg. 1999;121:263-268.
7. Al-Khudari S, Loochtan MJ, Peterson E, Yaremchuk KL. Management of angiotensin-converting enzyme inhibitor-induced angioedema. Laryngoscope. 2011;121:2327-2334.
8. Roberts DS, Mahoney EJ, Hutchinson CT, Aliphas A, Grundfast KM. Analysis of recurrent angiotensin converting enzyme inhibitor-induced angioedema. Laryngoscope. 2008;118:2115-2120.
9. Chiu AG, Newkirk KA, Davidson BJ, Burningham AR, Krowiak EJ, Deeb ZE. Angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter review and an algorithm for airway management. Ann Otol Rhinol Laryngol. 2001;110:834-840.